Mirati Therapeutics | Betriebsaufwand


Operating Expenses Veränderung
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Astellas Pharma 4503:JP 348.64B 31.09B
AstraZeneca AZN:LN 840.42B 39.99B
Bayer BAYN:GR 12.65B 2.22B
Biocryst Pharmaceuticals BCRX:US $ 100.25M 374K
Bluebird Bio BLUE:US $ 108.92M 13.37M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Eisai 4523:JP Y 176828M 34876M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Exelixis EXEL:US $ 335.72M 62.98M
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 584.8B 95.1B
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Johnson & Johnson JNJ:US $ 18.18B 616M
Merk MRK:US $ 9666M 666M
Moderna Inc MRNA:US 2.3B 463M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Spectrum Pharmaceuticals SPPI:US $ 25.39M 11.33M
Takeda 4502:JP 821.95B 52.96B
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
YTE INCY:US $ 656.97M 40.27M



Mirati Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.